Villejuif
100% dedicated to research
International cancer research agency
The Villejuif campus is an exceptional environment dedicated to accelerating cancer research and innovation. The campus brings together an ecosystem of international renown. This ecosystem includes the Institut Curie, Institut Gustave Roussy, Inserm, Université Paris-Saclay, Institut Polytechnique de Paris, Sanofi and more than 80 other organisations and start-ups. In addition, Villejuif offers access to the Paris-Saclay cancer cluster.
Facts & figures about Villejuif
Want to know more about Kadans projects on the Villejuif campus in Paris?
Elise Colla
M: +33 6 17 19 41 51 E: e.colla@kadans.com
Elise Colla M: +33 6 17 19 41 51 E: e.colla@kadans.com
Want to know more about Kadans projects on the Villejuif campus in Paris?
Elise Colla
M: +33 6 17 19 41 51 E: e.colla@kadans.com
Paris Saclay Cancer Cluster
The Paris Saclay Cancer Cluster (PSCC) was created in January 2022 with the aim of bringing together those involved in cancer innovation (researchers, clinicians, start-ups, entrepreneurs, investors, patients and institutions) in a location conducive to exchanges and accelerating the transformation of science into value for patients. The aim is to facilitate the development of new cancer treatments, medical devices and diagnostics in France by supporting commercial projects at different levels of maturity and connecting them with the experts, platforms and resources they need.
A building for innovation and research
Kadans Science Partner is building a multi-tenant building at Villejuif with an eye on research and innovation. The building will cover approximately 25.000 m2, with options for office or laboratory space starting from 50 m2. In addition, the building will include a cafeteria and meeting rooms, and a conference room open to the public.